Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 6/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 8/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7633115 | 0.83 | — | — | |
| SCHEMBL9974576 | 0.78 | CES2 (0.43) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL17510336 | 0.78 | CES2 (0.43) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL503761 | 0.76 | CES2 (0.39) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL23642215 | 0.76 | CES2 (0.44) | CES2LPAR1LPAR3CES1EPHX1 | |
| SCHEMBL6037238 | 0.75 | CES2 (0.46) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL22268683 | 0.75 | CES2 (0.46) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL30892683 | 0.75 | CES2 (0.46) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL17510328 | 0.75 | CES2 (0.46) | CES2LPAR1LPAR3CES1FAAH | |
| SCHEMBL45268 | 0.75 | CES2 (0.46) | CES2LPAR1LPAR3CES1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8465850-B2 | Method for the application of active materials onto a surface and devices made with such methods | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-18 | — | — | US | disclosed |
| US-8287766-B2 | depositing fluorinated aryl ethers and polyanilines or polythiophenes combined with fluorinated polysulfonic acids and/or mixtures, onto glass substrates, useful in organic electronic devices; organic light emitting diodes | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-10-16 | — | — | US | disclosed |
| US-20110180761-A1 | METHOD FOR THE APPLICATION OF ACTIVE MATERIALS ONTO A SURFACES AND DEVICES MADE WITH SUCH METHODS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-28 | — | — | US | disclosed |
| US-7686978-B2 | Method for the application of active materials onto active surfaces and devices made with such methods | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-03-30 | — | — | US | disclosed |
| US-7531700-B2 | Fluorinated arylethers and methods for use thereof | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-05-12 | — | — | US | disclosed |
| US-20050269550-A1 | Method for the application of active materials onto active surfaces and devices made with such methods | PETROV VIACHESLAV A | 2005-12-08 | — | — | US | disclosed |
| WO-2005030688-A2 | FLUORINATED ARYLETHERS AND METHODS FOR USE THEREOF | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005031889-A2 | METHOD FOR THE APPLICATION OF ACTIVE MATERIALS ONTO ACTIVE SURFACES AND DEVICES MADE WITH SUCH METHODS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20050062021-A1 | Method for the application of active materials onto active surfaces and devices made with such methods | LG CHEM, LTD. (KR) | 2005-03-24 | — | — | US | disclosed |
| US-20050065382-A1 | Fluorinated arylethers and methods for use thereof | E.I. DU PONT DE NEMOURS AND COMPANY | 2005-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065382-A1 | Fluorinated arylethers and methods for use thereof | CYP2F1, FLI1, AOX1 | CES2 84/4885LPAR1 2042/4885LPAR3 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.